{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T13:46:54Z","timestamp":1743083214113,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071618783"},{"type":"electronic","value":"9781071618790"}],"license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1879-0_19","type":"book-chapter","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T11:03:36Z","timestamp":1635419016000},"page":"271-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Humanized Mice for the Study of Dengue Disease Pathogenesis: Biological Assays"],"prefix":"10.1007","author":[{"given":"Hernando","family":"Gutierrez-Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Medina-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel V.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"528","key":"19_CR1","doi-asserted-by":"publisher","first-page":"eaax4144","DOI":"10.1126\/scitranslmed.aax4144","volume":"12","author":"L Cattarino","year":"2020","unstructured":"Cattarino L, Rodriguez-Barraquer I, Imai N et al (2020) Mapping global variation in dengue transmission intensity. Sci Transl Med 12(528):eaax4144","journal-title":"Sci Transl Med"},{"issue":"7446","key":"19_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ et al (2013) The global distribution and burden of dengue. Nature 496(7446):504\u2013507","journal-title":"Nature"},{"issue":"1","key":"19_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/vaccines8010063","volume":"8","author":"S-Q Deng","year":"2020","unstructured":"Deng S-Q, Yang X, Wei Y et al (2020) A review on dengue vaccine development. Vaccine 8(1):63","journal-title":"Vaccine"},{"issue":"10","key":"19_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","volume":"15","author":"SJ Thomas","year":"2019","unstructured":"Thomas SJ, Yoon I-K (2019) A review of Dengvaxia\u00ae: development to deployment. Hum Vaccin Immunother 15(10):2295\u20132314","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"19_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Luedtke A, Langevin E et al (2018) Effect of dengue Serostatus on dengue vaccine safety and efficacy. N Engl J Med 379(4):327\u2013340","journal-title":"N Engl J Med"},{"issue":"1","key":"19_CR6","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S1473-3099(18)30494-8","volume":"19","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith A, Hombach J, Ferguson N et al (2019) Deliberations of the strategic advisory Group of Experts on immunization on the use of CYD-TDV dengue vaccine. Lancet Infect Dis 19(1):e31\u2013e38","journal-title":"Lancet Infect Dis"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","volume":"144","author":"EZ Ong","year":"2017","unstructured":"Ong EZ, Budigi Y, Tan HC et al (2017) Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates. Antivir Res 144:44\u201347","journal-title":"Antivir Res"},{"issue":"7","key":"19_CR8","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1021\/acsinfecdis.8b00054","volume":"4","author":"S Watanabe","year":"2018","unstructured":"Watanabe S, Low JG-H, Vasudevan SG (2018) Preclinical antiviral testing for dengue virus infection in mouse models and its association with clinical studies. ACS Infect Dis 4(7):1048\u20131057","journal-title":"ACS Infect Dis"},{"issue":"7","key":"19_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04506","volume":"6","author":"M Yoshimura","year":"2020","unstructured":"Yoshimura M, Shinmura Y, Takagi S et al (2020) Well-balanced immune response and protective efficacy induced by a single dose of live attenuated tetravalent dengue vaccine (KD-382) in monkeys. Heliyon 6(7):e04506","journal-title":"Heliyon"},{"issue":"1","key":"19_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40794-020-00111-5","volume":"6","author":"G El Helou","year":"2020","unstructured":"El Helou G, Ponzio TA, Goodman JF et al (2020) Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands. Trop Dis Travel Med Vaccines 6(1):10","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fimmu.2014.00452","volume":"5","author":"CA Sariol","year":"2014","unstructured":"Sariol CA, White LJ (2014) Utility, limitations, and future of non-human primates for dengue research and vaccine development. Front Immunol 5:452. https:\/\/doi.org\/10.3389\/fimmu.2014.00452","journal-title":"Front Immunol"},{"issue":"4","key":"19_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/pathogens9040247","volume":"9","author":"NA Muhammad Azami","year":"2020","unstructured":"Muhammad Azami NA, Takasaki T, Kurane I et al (2020) Non-human primate models of dengue virus infection: a comparison of viremia levels and antibody responses during primary and secondary infection among Old World and New World monkeys. Pathogens 9(4):247","journal-title":"Pathogens"},{"issue":"9","key":"19_CR13","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo F, Pugachev K, Zhang Z et al (2004) Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol 78(9):4761\u20134775","journal-title":"J Virol"},{"issue":"3","key":"19_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019368","volume":"9","author":"BR Rosa","year":"2019","unstructured":"Rosa BR, da Cunha AJLA, de Medronho RA (2019) Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2\u201317 years: systematic review and meta-analysis. BMJ Open 9(3):e019368","journal-title":"BMJ Open"},{"issue":"5","key":"19_CR15","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CCW (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172(5):2731\u20132738","journal-title":"J Immunol"},{"issue":"4","key":"19_CR16","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/nar\/gky018","volume":"46","author":"AG Diehl","year":"2018","unstructured":"Diehl AG, Boyle AP (2018) Conserved and species-specific transcription factor co-binding patterns drive divergent gene regulation in human and mouse. Nucleic Acids Res 46(4):1878\u20131894","journal-title":"Nucleic Acids Res"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","volume":"5","author":"RM Zellweger","year":"2014","unstructured":"Zellweger RM, Shresta S (2014) Mouse models to study dengue virus immunology and pathogenesis. Front Immunol 5:151. https:\/\/doi.org\/10.3389\/fimmu.2014.00151","journal-title":"Front Immunol"},{"issue":"5","key":"19_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-017-0625-1","volume":"39","author":"A Srikiatkhachorn","year":"2017","unstructured":"Srikiatkhachorn A, Mathew A, Rothman AL (2017) Immune-mediated cytokine storm and its role in severe dengue. Semin Immunopathol 39(5):563\u2013574","journal-title":"Semin Immunopathol"},{"issue":"1","key":"19_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/vaccines8010039","volume":"8","author":"C Coronel-Ruiz","year":"2020","unstructured":"Coronel-Ruiz C, Guti\u00e9rrez-Barbosa H, Medina-Moreno S et al (2020) Humanized mice in dengue research: a comparison with other mouse models. Vaccine 8(1):39","journal-title":"Vaccine"},{"issue":"1","key":"19_CR20","first-page":"61","volume":"48","author":"DK Taylor","year":"2009","unstructured":"Taylor DK, Mook DM (2009) Isoflurane waste anesthetic gas concentrations associated with the open-drop method. J Am Assoc Lab Anim Sci 48(1):61\u201364","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"6","key":"19_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020762","volume":"6","author":"J Mota","year":"2011","unstructured":"Mota J, Rico-Hesse R (2011) Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS One 6(6):e20762","journal-title":"PLoS One"},{"issue":"17","key":"19_CR22","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1128\/JVI.00581-09","volume":"83","author":"J Mota","year":"2009","unstructured":"Mota J, Rico-Hesse R (2009) Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 83(17):8638\u20138645","journal-title":"J Virol"},{"issue":"1","key":"19_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bjid.2019.11.003","volume":"24","author":"H Guti\u00e9rrez-Barbosa","year":"2020","unstructured":"Guti\u00e9rrez-Barbosa H, Casta\u00f1eda NY, Castellanos JE (2020) Differential replicative fitness of the four dengue virus serotypes circulating in Colombia in human liver Huh7 cells. Brazilian J Infect Dis 24(1):13\u201324","journal-title":"Brazilian J Infect Dis"},{"issue":"7","key":"19_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002311","volume":"7","author":"GA Santiago","year":"2013","unstructured":"Santiago GA, Vergne E, Quiles Y et al (2013) Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis 7(7):e2311","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Methods in Molecular Biology","Dengue Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1879-0_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T11:04:45Z","timestamp":1635419085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1879-0_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"ISBN":["9781071618783","9781071618790"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1879-0_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"29 October 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}